Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Accumulation of radioiodinated L-. cap alpha. -methyltyrosine in pancreas of mice: concise communication. [/sup 131/I, /sup 123/I]

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5606776
L-3-iodo-..cap alpha..-methyltyrosine, labeled with either I-131 or I-123, has a high pancreatic specificity in mice. A pancreas-to-liver ratio of 8.6 +- 2.7 is observed during the first hour after i.v. injection. Accumulation is also prominent in the kidneys, but excretion of the radioagent is rapid, 50% of the activity being eliminated during 90 min. Compared with L-(/sup 75/Se)selenomethionine, the compound currently used for pancreatic imaging, L-3-(/sup 123/I) or (/sup 131/I)iodo-..cap alpha..-methyltyrosine has a greater pancreas-to-liver ratio, a shorter physical half-life and biological half-time, and better decay characteristics.
Research Organization:
Kernforschungsanlage Julich, Germany
OSTI ID:
5606776
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 20:9; ISSN JNMEA
Country of Publication:
United States
Language:
English

Similar Records

Pancreas accumulation of radioiodinated HIPDM in mice and rats
Journal Article · Mon Jul 01 00:00:00 EDT 1985 · J. Nucl. Med.; (United States) · OSTI ID:5410784

Human pancreas scintigraphy using iodine-123-labeled HIPDM and SPECT
Journal Article · Fri Jun 01 00:00:00 EDT 1990 · Journal of Nuclear Medicine; (USA) · OSTI ID:6717453

Growth-hormone and somatostatin effects on (/sup 75/Se)selenomethionine uptake by the pancreas
Journal Article · Fri Jun 01 00:00:00 EDT 1979 · J. Nucl. Med.; (United States) · OSTI ID:5734033